BRCA1/2 negative status predicts no extended risk of invasive ovarian cancer.

The article presents a study which discusses the extended risk of invasive ovarian cancer to patients with BRCA genes negative status. The study used a long-term prospective study to assess the risk of invasive ovarian cancer among 8005 women from families with history of BRCA1/2 mutations. Results show that women who were positive to BRCA1/2 mutation have an increased risk of invasive ovarian cancer compared to BRCA negative women.